c-diGMPおよびc-diAMPアナログ製品
c-diGMP and c-diAMP Analogues
| 製品名 | 製品番号 | 容量 |
| 2'3'-cGAMP | ||
| Cyclic (guanosine- (2' −> 5')- monophosphate- adenosine- (3' −> 5')- monophosphate) ( c[G(2',5')pA(3',5')p] / cGAMP(2'-5') / 2'3'-cGAMP / 2',5'-3',5'-cGAMP ) | C 161-005 | 0.5 µmol / ～335 µg |
| Cyclic (guanosine- (2' −> 5')- monophosphate- adenosine- (3' −> 5')- monophosphate) ( c[G(2',5')pA(3',5')p] / cGAMP(2'-5') / 2'3'-cGAMP / 2',5'-3',5'-cGAMP ) | C 161-025 | 5 x 0.5 µmol |
| Cyclic (8- bromoguanosine- (2' −> 5')- monophosphate- adenosine- (3' −> 5')- monophosphate) ( c[8-Br-G(2',5')pA(3',5')p] ) | C 172-001 | 0.1 µmol / ～75 µg |
| Cyclic (8- bromoguanosine- (2' −> 5')- monophosphate- adenosine- (3' −> 5')- monophosphate) ( c[8-Br-G(2',5')pA(3',5')p] ) | C 172-005 | 5 x 0.1 µmol |
| Cyclic (8- (2- aminoethylthio)guanosine- (2' −> 5')- monophosphate- adenosine- (3' −> 5')- monophosphate) ( c[8-AET-G(2',5')pA(3',5')p] ) | C 175-001 | 0.1 µmol / ～75 µg |
| Cyclic (8- (2- aminoethylthio)guanosine- (2' −> 5')- monophosphate- adenosine- (3' −> 5')- monophosphate) ( c[8-AET-G(2',5')pA(3',5')p] ) | C 175-005 | 5 x 0.1 µmol |
| Cyclic (8- (2- [biotinyl]aminoethylthio)- guanosine- (2' −> 5')- monophosphate- adenosine- (3' −> 5')- monophosphate) ( c[8-[Biotin]-AET-G(2',5')pA(3',5')p] ) | C 176-001 | 0.1 µmol / ～0.1 mg |
| Cyclic (8- (2- [biotinyl]aminoethylthio)- guanosine- (2' −> 5')- monophosphate- adenosine- (3' −> 5')- monophosphate) ( c[8-[Biotin]-AET-G(2',5')pA(3',5')p] ) | C 176-005 | 5 x 0.1 µmol |
| Cyclic (8- (2- [fluoresceinyl]aminoethylthio)- guanosine- (2' −> 5')- monophosphate- adenosine- (3' −> 5')- monophosphate) ( c[8-Fluo-AET-G(2',5')pA(3',5')p] / 8-Fluo-AET-cGAMP(2'-5') ) | C 178-001 | 0.1 µmol / ～0.1 mg |
| Cyclic (8- (2- [fluoresceinyl]aminoethylthio)- guanosine- (2' −> 5')- monophosphate- adenosine- (3' −> 5')- monophosphate) ( c[8-Fluo-AET-G(2',5')pA(3',5')p] / 8-Fluo-AET-cGAMP(2'-5') ) | C 178-005 | 5 x 0.1 µmol |
| Cyclic (8- (2- aminoethylthio)guanosine- (2' −> 5')- monophosphate- adenosine- (3' −> 5')- monophosphate), immobilized on agarose gel ( c[8-AET-G(2',5')pA(3',5')p]-Agarose ) | C 184-06 | 0.6 ml |
| Cyclic (8- (2- aminoethylthio)guanosine- (2' −> 5')- monophosphate- adenosine- (3' −> 5')- monophosphate), immobilized on agarose gel ( c[8-AET-G(2',5')pA(3',5')p]-Agarose ) | C 184-25 | 2.5 ml |
| Cyclic (8- (2- aminoethylthio)guanosine- (2' −> 5')- monophosphate- adenosine- (3' −> 5')- monophosphate), immobilized on agarose gel ( c[8-AET-G(2',5')pA(3',5')p]-Agarose ) | C 184-60 | 6 ml |
| Cyclic (3'- O- (6- aminohexylcarbamoyl)guanosine- (2' −> 5')- monophosphate- adenosine- (3' −> 5')- monophosphate) ( c[3'-AHC-G(2',5')pA(3',5')p] ) | C 191-001 | 0.1 µmol / ～82 µg |
| Cyclic (3'- O- (6- aminohexylcarbamoyl)guanosine- (2' −> 5')- monophosphate- adenosine- (3' −> 5')- monophosphate) ( c[3'-AHC-G(2',5')pA(3',5')p] ) | C 191-005 | 5 x 0.1 µmol |
| Cyclic (guanosine- (2' −> 5')- monophosphate- 2'- O- (6- aminohexylcarbamoyl)adenosine- (3' −> 5')- monophosphate) ( c[G(2',5')p-2'-AHC-A(3',5')p] ) | C 192-001 | 0.1 µmol / ～82 µg |
| Cyclic (guanosine- (2' −> 5')- monophosphate- 2'- O- (6- aminohexylcarbamoyl)adenosine- (3' −> 5')- monophosphate) ( c[G(2',5')p-2'-AHC-A(3',5')p] ) | C 192-005 | 5 x 0.1 µmol |
| Cyclic (guanosine- (2' −> 5')- monophosphate- 2'- deoxyadenosine- (3' −> 5')- monophosphate) ( c[G(2',5')p-2'-dA(3',5')p] ) | C 193-001 | 0.1 µmol / ～66 µg |
| Cyclic (guanosine- (2' −> 5')- monophosphate- 2'- deoxyadenosine- (3' −> 5')- monophosphate) ( c[G(2',5')p-2'-dA(3',5')p] ) | C 193-005 | 5 x 0.1 µmol |
| Cyclic (3'- O- (6- [fluoresceinyl]aminohexylcarbamoyl)guanosine- (2' −> 5')- monophosphate- adenosine- (3' −> 5')- monophosphate) ( c[3'-Fluo-AHC-G(2',5')pA(3',5')p] ) | C 194-001 | 0.1 µmol / ～0.1 mg |
| Cyclic (3'- O- (6- [fluoresceinyl]aminohexylcarbamoyl)guanosine- (2' −> 5')- monophosphate- adenosine- (3' −> 5')- monophosphate) ( c[3'-Fluo-AHC-G(2',5')pA(3',5')p] ) | C 194-005 | 5 x 0.1 µmol |
| Cyclic (guanosine- (2' −> 5')- monophosphate- 2'- O- (6- [fluoresceinyl]aminohexylcarbamoyl)adenosine- (3' −> 5')- monophosphate) ( c[G(2',5')p-2'-Fluo-AHC-A(3',5')p] ) | C 195-001 | 0.1 µmol / ～0.1 mg |
| Cyclic (guanosine- (2' −> 5')- monophosphate- 2'- O- (6- [fluoresceinyl]aminohexylcarbamoyl)adenosine- (3' −> 5')- monophosphate) ( c[G(2',5')p-2'-Fluo-AHC-A(3',5')p] ) | C 195-005 | 5 x 0.1 µmol |
| Cyclic (3'- O- (6- [biotinyl]aminohexylcarbamoyl)guanosine- (2' −> 5')- monophosphate- adenosine- (3' −> 5')- monophosphate) ( c[3'-[Biotin]-AHC-G(2',5')pA(3',5')p] ) | C 196-001 | 0.1 µmol / ～0.1 mg |
| Cyclic (3'- O- (6- [biotinyl]aminohexylcarbamoyl)guanosine- (2' −> 5')- monophosphate- adenosine- (3' −> 5')- monophosphate) ( c[3'-[Biotin]-AHC-G(2',5')pA(3',5')p] ) | C 196-005 | 5 x 0.1 µmol |
| Cyclic (guanosine- (2' −> 5')- monophosphate- 2'- O- (6- [biotinyl]aminohexylcarbamoyl)adenosine- (3' −> 5')- monophosphate) ( c[G(2',5')p-2'-[Biotin]-AHC-A(3',5')p] ) | C 197-001 | 0.1 µmol / ～0.1 mg |
| Cyclic (guanosine- (2' −> 5')- monophosphate- 2'- O- (6- [biotinyl]aminohexylcarbamoyl)adenosine- (3' −> 5')- monophosphate) ( c[G(2',5')p-2'-[Biotin]-AHC-A(3',5')p] ) | C 197-005 | 5 x 0.1 µmol |
| 3'3'-cGAMP | ||
| Cyclic (adenosine monophosphate- guanosine monophosphate) ( c-(ApGp) / cGAMP / 3'3'-cGAMP / cyclic GMP-AMP / cyclic-AMP-GMP / c[G(3',5')pA(3',5')p] ) | C 117-005 | 0.5 µmol / ～337 µg |
| Cyclic (adenosine monophosphate- guanosine monophosphate) ( c-(ApGp) / cGAMP / 3'3'-cGAMP / cyclic GMP-AMP / cyclic-AMP-GMP / c[G(3',5')pA(3',5')p] ) | C 117-025 | 5 x 0.5 µmol |
| Cyclic (adenosine monophosphate- 8- bromoguanosine monophosphate) ( c-(Ap-8-Br-Gp) / 8-Br-cGAMP ) | C 145-001 | 0.1 µmol / ～75 µg |
| Cyclic (adenosine monophosphate- 8- bromoguanosine monophosphate) ( c-(Ap-8-Br-Gp) / 8-Br-cGAMP ) | C 145-005 | 5 x 0.1 µmol |
| Cyclic (adenosine monophosphate- 8- (2- aminoethylthio)guanosine monophosphate) ( c-(Ap-8-AET-Gp) / 8-AET-cGAMP ) | C 149-001 | 0.1 µmol / ～75 µg |
| Cyclic (adenosine monophosphate- 8- (2- aminoethylthio)guanosine monophosphate) ( c-(Ap-8-AET-Gp) / 8-AET-cGAMP ) | C 149-005 | 5 x 0.1 µmol |
| Cyclic (adenosine monophosphate- 8- (2- [biotinyl]aminoethylthio)guanosine monophosphate) ( c-(Ap-8-[Biotin]-AET-Gp) / 8-[Biotin]-AET-cGAMP ) | C 157-001 | 0.1 µmol / ～0.1 mg |
| Cyclic (adenosine monophosphate- 8- (2- [biotinyl]aminoethylthio)guanosine monophosphate) ( c-(Ap-8-[Biotin]-AET-Gp) / 8-[Biotin]-AET-cGAMP ) | C 157-005 | 5 x 0.1 µmol |
| Cyclic (adenosine monophosphate- 8- (2- [fluoresceinyl]aminoethylthio)guanosine monophosphate) ( c-(Ap-8-Fluo-AET-Gp) / 8-Fluo-AET-cGAMP ) | C 159-001 | 0.1 µmol / ～0.1 mg |
| Cyclic (adenosine monophosphate- 8- (2- [fluoresceinyl]aminoethylthio)guanosine monophosphate) ( c-(Ap-8-Fluo-AET-Gp) / 8-Fluo-AET-cGAMP ) | C 159-005 | 5 x 0.1 µmol |
| Cyclic (adenosine monophosphate- 8- (2- aminoethylthio)guanosine monophosphate), immobilized on agarose gel ( c-(Ap-8-AET-Gp)-Agarose ) | C 166-06 | 0.6 ml |
| Cyclic (adenosine monophosphate- 8- (2- aminoethylthio)guanosine monophosphate), immobilized on agarose gel ( c-(Ap-8-AET-Gp)-Agarose ) | C 166-25 | 2.5 ml |
| Cyclic (adenosine monophosphate- 8- (2- aminoethylthio)guanosine monophosphate), immobilized on agarose gel ( c-(Ap-8-AET-Gp)-Agarose ) | C 166-60 | 6 ml |
| c-di-AMP | ||
| Cyclic diadenosine monophosphate ( c-diAMP / c-di-AMP / cyclic bis (3' −> 5') diadenylic acid ) | C 088-01 | 1 µmol / ～0.7 mg |
| Cyclic diadenosine monophosphate ( c-diAMP / c-di-AMP / cyclic bis (3' −> 5') diadenylic acid ) | C 088-05 | 5 x 1 µmol |
| 2'- O- (6- Aminohexylcarbamoyl)- cyclic diadenosine monophosphate ( 2'-AHC-c-diAMP ) | A 182-001 | 0.1 µmol / ～80 µg |
| 2'- O- (6- Aminohexylcarbamoyl)- cyclic diadenosine monophosphate ( 2'-AHC-c-diAMP ) | A 182-005 | 5 x 0.1 µmol |
| 2'- O- (6- Aminohexylcarbamoyl)- cyclic diadenosine monophosphate, immobilized on agarose ( 2'-AHC-c-diAMP-Agarose ) | A 183-06 | 0.6 ml |
| 2'- O- (6- Aminohexylcarbamoyl)- cyclic diadenosine monophosphate, immobilized on agarose ( 2'-AHC-c-diAMP-Agarose ) | A 183-25 | 2.5 ml |
| 2'- O- (6- Aminohexylcarbamoyl)- cyclic diadenosine monophosphate, immobilized on agarose ( 2'-AHC-c-diAMP-Agarose ) | A 183-60 | 6 ml |
| 8- (2- Aminoethylthio)- cyclic diadenosine monophosphate ( 8-AET-c-diAMP ) | A 220-001 | 0.1 µmol / ～73 µg |
| 8- (2- Aminoethylthio)- cyclic diadenosine monophosphate ( 8-AET-c-diAMP ) | A 220-005 | 5 x 0.1 µmol |
| 8- (2- Aminoethylthio)- cyclic diadenosine monophosphate, immobilized on agarose gel ( 8-AET-c-diAMP-Agarose ) | A 234-06 | 0.6 ml |
| 8- (2- Aminoethylthio)- cyclic diadenosine monophosphate, immobilized on agarose gel ( 8-AET-c-diAMP-Agarose ) | A 234-25 | 2.5 ml |
| 8- (2- Aminoethylthio)- cyclic diadenosine monophosphate, immobilized on agarose gel ( 8-AET-c-diAMP-Agarose ) | A 234-60 | 6 ml |
| 2'- O- (6- [ Biotinyl]aminohexylcarbamoyl)- cyclic diadenosine monophosphate ( 2'-[Biotin]-AHC-c-diAMP ) | B 106-001 | 0.1 µmol / ～0.1 mg |
| 2'- O- (6- [ Biotinyl]aminohexylcarbamoyl)- cyclic diadenosine monophosphate ( 2'-[Biotin]-AHC-c-diAMP ) | B 106-005 | 5 x 0.1 µmol |
| 8- (2- [ Biotinyl]aminoethylthio)- cyclic diadenosine monophosphate, ( 8-[Biotin]-AET-c-diAMP ) | B 156-001 | 0.1 µmol / ～0.1 mg |
| 8- (2- [ Biotinyl]aminoethylthio)- cyclic diadenosine monophosphate, ( 8-[Biotin]-AET-c-diAMP ) | B 156-005 | 5 x 0.1 µmol |
| 8- Chloro- cyclic diadenosine monophosphate ( 8-Cl-c-diAMP ) | C 146-001 | 0.1 µmol / ～69 µg |
| 8- Chloro- cyclic diadenosine monophosphate ( 8-Cl-c-diAMP ) | C 146-005 | 5 x 0.1 µmol |
| 2'-, 2''- O- ( Di- [6- aminohexylcarbamoyl])- cyclic diadenosine monophosphate ( 2',2''-Di-AHC-c-diAMP ) | D 121-001 | 0.1 µmol / ～94 µg |
| 2'-, 2''- O- ( Di- [6- aminohexylcarbamoyl])- cyclic diadenosine monophosphate ( 2',2''-Di-AHC-c-diAMP ) | D 121-005 | 5 x 0.1 µmol |
| 2', 2''- O- ( Di- 6- [biotinyl]aminohexylcarbamoyl)- cyclic diadenosine monophosphate ( 2',2''-Di-[Biotin]-AHC-c-diAMP ) | D 122-001 | 0.1 µmol / ～0.2 mg |
| 2', 2''- O- ( Di- 6- [biotinyl]aminohexylcarbamoyl)- cyclic diadenosine monophosphate ( 2',2''-Di-[Biotin]-AHC-c-diAMP ) | D 122-005 | 5 x 0.1 µmol |
| 2'-, 2''- Dideoxy- 2'-, 2''- difluoro- cyclic diadenosine monophosphate ( 2',2''-Di-F-c-didAMP ) | D 132-001 | 0.1 µmol / ～66 µg |
| 2'-, 2''- Dideoxy- 2'-, 2''- difluoro- cyclic diadenosine monophosphate ( 2',2''-Di-F-c-didAMP ) | D 132-005 | 5 x 0.1 µmol |
| 2'-, 2''- Dideoxy- cyclic diadenosine monophosphate ( 2',2''-Di-c-didAMP ) | D 140-001 | 0.1 µmol / ～63 µg |
| 2'-, 2''- Dideoxy- cyclic diadenosine monophosphate ( 2',2''-Di-c-didAMP ) | D 140-005 | 5 x 0.1 µmol |
| 2'- Deoxy- 2''- O- methyl- cyclic diadenosine monophosphate ( c-di-2'-d-2''-O-Me-AMP / c-(2'-dAp-2'-O-Me-Ap) ) | D 143-001 | 0.1 µmol / ～66 µg |
| 2'- Deoxy- 2''- O- methyl- cyclic diadenosine monophosphate ( c-di-2'-d-2''-O-Me-AMP / c-(2'-dAp-2'-O-Me-Ap) ) | D 143-005 | 5 x 0.1 µmol |
| 2'- Deoxy- cyclic diadenosine monophosphate ( c-di-2'-dAMP / c-(2'-dApAp) ) | D 144-001 | 0.1 µmol / ～64 µg |
| 2'- Deoxy- cyclic diadenosine monophosphate ( c-di-2'-dAMP / c-(2'-dApAp) ) | D 144-005 | 5 x 0.1 µmol |
| 2'-, 2''- O- ( Di- methyl)- cyclic diadenosine monophosphate ( 2',2''-Di-O-Me-c-diAMP ) | D 154-001 | 0.1 µmol / ～69 µg |
| 2'-, 2''- O- ( Di- methyl)- cyclic diadenosine monophosphate ( 2',2''-Di-O-Me-c-diAMP ) | D 154-005 | 5 x 0.1 µmol |
| 2'-, 2''- O- ( Di- N'- methylanthraniloyl)- cyclic diadenosine monophosphate ( Di-MANT-c-diAMP ) | D 159-001 | 0.1 µmol / ～92 µg |
| 2'-, 2''- O- ( Di- N'- methylanthraniloyl)- cyclic diadenosine monophosphate ( Di-MANT-c-diAMP ) | D 159-005 | 5 x 0.1 µmol |
| 2'- O- (6- [ Fluoresceinyl]aminohexylcarbamoyl)- cyclic diadenosine monophosphate ( 2'-Fluo-AHC-c-diAMP ) | F 011-001 | 0.1 µmol / ～0.1 mg |
| 2'- O- (6- [ Fluoresceinyl]aminohexylcarbamoyl)- cyclic diadenosine monophosphate ( 2'-Fluo-AHC-c-diAMP ) | F 011-005 | 5 x 0.1 µmol |
| 2'- O- Methyl- cyclic diadenosine monophosphate ( 2'-O-Me-c-diAMP / c-(2'-O-Me-ApAp) ) | M 085-001 | 0.1 µmol / ～67 µg |
| 2'- O- Methyl- cyclic diadenosine monophosphate ( 2'-O-Me-c-diAMP / c-(2'-O-Me-ApAp) ) | M 085-005 | 5 x 0.1 µmol |
| 2'- O- (N'- Methylanthraniloyl)- cyclic diadenosine monophosphate ( MANT-c-diAMP ) | M 103-001 | 0.1 µmol / ～79 µg |
| 2'- O- (N'- Methylanthraniloyl)- cyclic diadenosine monophosphate ( MANT-c-diAMP ) | M 103-005 | 5 x 0.1 µmol |
| Cyclic diadenosine monophosphorodithioate, Rp- isomers ( Rp,Rp-c-diAMPSS ) | C 118-001 | 0.1 µmol / ～69 µg |
| Cyclic diadenosine monophosphorodithioate, Rp- isomers ( Rp,Rp-c-diAMPSS ) | C 118-005 | 5 x 0.1 µmol |
| Cyclic diadenosine monophosphorodithioate, Rp- / Sp- isomers ( Rp,Sp-c-diAMPSS ) | C 119-001 | 0.1 µmol / ～69 µg |
| Cyclic diadenosine monophosphorodithioate, Rp- / Sp- isomers ( Rp,Sp-c-diAMPSS ) | C 119-005 | 5 x 0.1 µmol |
| Cyclic diadenosine monophosphorothioate, Rp- isomer ( Rp-c-diAMPS ) | C 121-001 | 0.1 µmol / ～67 µg |
| Cyclic diadenosine monophosphorothioate, Rp- isomer ( Rp-c-diAMPS ) | C 121-005 | 5 x 0.1 µmol |
| Cyclic diadenosine monophosphorothioate, Sp- isomer ( Sp-c-diAMPS ) | C 122-001 | 0.1 µmol / ～67 µg |
| Cyclic diadenosine monophosphorothioate, Sp- isomer ( Sp-c-diAMPS ) | C 122-005 | 5 x 0.1 µmol |
| 5'- Phosphoadenylyl- (3' −> 5')- adenosine ( pApA ) | P 033-001 | 0.1 µmol / ～68 µg |
| 5'- Phosphoadenylyl- (3' −> 5')- adenosine ( pApA ) | P 033-005 | 5 x 0.1 µmol |
| c-di-GMP | ||
| Cyclic diguanosine monophosphate ( c-diGMP / c-di-GMP ) / cyclic bis ( 3' −> 5' ) diguanylic acid / cyclic diguanylate | C 057-01 | 1 µmol / ～0.7 mg |
| Cyclic diguanosine monophosphate ( c-diGMP / c-di-GMP ) / cyclic bis ( 3' −> 5' ) diguanylic acid / cyclic diguanylate | C 057-05 | 5 x 1 µmol |
| 2'- O- (6- Aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2'-AHC-c-diGMP ) | A 151-001 | 0.1 µmol / ～83 µg |
| 2'- O- (6- Aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2'-AHC-c-diGMP ) | A 151-005 | 5 x 0.1 µmol |
| 2'- O- (6- Aminohexylcarbamoyl)- cyclic diguanosine monophosphate, immobilized on agarose ( 2'-AHC-c-diGMP-Agarose ) | A 153-06 | 0.6 ml |
| 2'- O- (6- Aminohexylcarbamoyl)- cyclic diguanosine monophosphate, immobilized on agarose ( 2'-AHC-c-diGMP-Agarose ) | A 153-25 | 2.5 ml |
| 2'- O- (6- Aminohexylcarbamoyl)- cyclic diguanosine monophosphate, immobilized on agarose ( 2'-AHC-c-diGMP-Agarose ) | A 153-60 | 6 ml |
| 8- (2- Aminoethylthio)- cyclic diguanosine monophosphate ( 8-AET-c-diGMP ) | A 232-001 | 0.1 µmol / ～77 µg |
| 8- (2- Aminoethylthio)- cyclic diguanosine monophosphate ( 8-AET-c-diGMP ) | A 232-005 | 5 x 0.1 µmol |
| 8- (2- Aminoethylthio)- cyclic diguanosine monophosphate, immobilized on agarose gel ( 8-AET-c-diGMP-Agarose ) | A 235-06 | 0.6 ml |
| 8- (2- Aminoethylthio)- cyclic diguanosine monophosphate, immobilized on agarose gel ( 8-AET-c-diGMP-Agarose ) | A 235-25 | 2.5 ml |
| 8- (2- Aminoethylthio)- cyclic diguanosine monophosphate, immobilized on agarose gel ( 8-AET-c-diGMP-Agarose ) | A 235-60 | 6 ml |
| 2'- O- (6- [ Biotinyl]aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2'-[Biotin]-AHC-c-diGMP ) | B 098-001 | 0.1 µmol / ～0.1 mg |
| 2'- O- (6- [ Biotinyl]aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2'-[Biotin]-AHC-c-diGMP ) | B 098-005 | 5 x 0.1 µmol |
| 8- Bromo- cyclic diguanosine monophosphate ( 8-Br-c-diGMP ) | B 099-001 | 0.1 µmol / ～77 µg |
| 8- Bromo- cyclic diguanosine monophosphate ( 8-Br-c-diGMP ) | B 099-005 | 5 x 0.1 µmol |
| 8- (2- [ Biotinyl]aminoethylthio)- cyclic diguanosine monophosphate ( 8-[Biotin]-AET-c-diGMP ) | B 184-001 | 0.1 µmol / ～0.1 mg |
| 8- (2- [ Biotinyl]aminoethylthio)- cyclic diguanosine monophosphate ( 8-[Biotin]-AET-c-diGMP ) | B 184-005 | 5 x 0.1 µmol |
| 2'-, 2''- O- ( Di- N'- methylanthraniloyl)- cyclic diguanosine monophosphate ( Di-MANT-c-diGMP ) | D 101-001 | 0.1 µmol / ～0.1 mg |
| 2'-, 2''- O- ( Di- N'- methylanthraniloyl)- cyclic diguanosine monophosphate ( Di-MANT-c-diGMP ) | D 101-005 | 5 x 0.1 µmol |
| 2'-, 2''- O- ( Di- 6- [biotinyl]aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2',2''-Di-[Biotin]-AHC-c-diGMP ) | D 111-001 | 0.1 µmol / ～0.2 mg |
| 2'-, 2''- O- ( Di- 6- [biotinyl]aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2',2''-Di-[Biotin]-AHC-c-diGMP ) | D 111-005 | 5 x 0.1 µmol |
| 2'-, 2''- O- ( Di- [6- aminohexylcarbamoyl])- cyclic diguanosine monophosphate ( 2',2''-Di-AHC-c-diGMP ) | D 112-001 | 0.1 µmol / ～97 µg |
| 2'-, 2''- O- ( Di- [6- aminohexylcarbamoyl])- cyclic diguanosine monophosphate ( 2',2''-Di-AHC-c-diGMP ) | D 112-005 | 5 x 0.1 µmol |
| 8-, 8'- Dibromo- cyclic diguanosine monophosphate ( 8,8'-Di-Br-c-diGMP ) | D 113-001 | 0.1 µmol / ～85 µg |
| 8-, 8'- Dibromo- cyclic diguanosine monophosphate ( 8,8'-Di-Br-c-diGMP ) | D 113-005 | 5 x 0.1 µmol |
| 2'- O- (6- [ DY-547]- aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2'-[DY-547]-AHC-c-diGMP ) | D 116-001 | 0.1 µmol / ～0.1 mg |
| 2'- O- (6- [ DY-547]- aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2'-[DY-547]-AHC-c-diGMP ) | D 116-005 | 5 x 0.1 µmol |
| 2'-, 2''- O- ( Di- methyl)- cyclic diguanosine monophosphate ( 2',2''-Di-O-Me-c-diGMP ) | D 136-001 | 0.1 µmol / ～72 µg |
| 2'-, 2''- O- ( Di- methyl)- cyclic diguanosine monophosphate ( 2',2''-Di-O-Me-c-diGMP ) | D 136-005 | 5 x 0.1 µmol |
| 2'-, 2''- Dideoxy- cyclic diguanosine monophosphate ( 2',2''-Di-c-didGMP ) | D 139-001 | 0.1 µmol / ～66 µg |
| 2'-, 2''- Dideoxy- cyclic diguanosine monophosphate ( 2',2''-Di-c-didGMP ) | D 139-005 | 5 x 0.1 µmol |
| 2'- Deoxy- cyclic diguanosine monophosphate ( c-di-2'-dGMP / c-(2'-dGpGp) / c-dG-GMP ) | D 145-001 | 0.1 µmol / ～67 µg |
| 2'- Deoxy- cyclic diguanosine monophosphate ( c-di-2'-dGMP / c-(2'-dGpGp) / c-dG-GMP ) | D 145-005 | 5 x 0.1 µmol |
| 2'- O- (6- [ Fluoresceinyl]aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2'-Fluo-AHC-c-diGMP ) | F 009-001 | 0.1 µmol / ～0.1 mg |
| 2'- O- (6- [ Fluoresceinyl]aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2'-Fluo-AHC-c-diGMP ) | F 009-005 | 5 x 0.1 µmol |
| 2'- O- Methyl- cyclic diguanosine monophosphate ( 2'-O-Me-c-diGMP / c-(2'-O-Me-GpGp) ) | M 086-001 | 0.1 µmol / ～70 µg |
| 2'- O- Methyl- cyclic diguanosine monophosphate ( 2'-O-Me-c-diGMP / c-(2'-O-Me-GpGp) ) | M 086-005 | 5 x 0.1 µmol |
| 2'- O- (N'- Methylanthraniloyl)- cyclic diguanosine monophosphate ( MANT-c-diGMP ) | M 102-001 | 0.1 µmol / ～82 µg |
| 2'- O- (N'- Methylanthraniloyl)- cyclic diguanosine monophosphate ( MANT-c-diGMP ) | M 102-005 | 5 x 0.1 µmol |
| Cyclic diguanosine monophosphorothioate, Rp- isomer ( Rp-c-diGMPS ) | C 124-001 | 0.1 µmol / ～71 µg |
| Cyclic diguanosine monophosphorothioate, Rp- isomer ( Rp-c-diGMPS ) | C 124-005 | 5 x 0.1 µmol |
| Cyclic diguanosine monophosphorothioate, Sp- isomer ( Sp-c-diGMPS ) | C 125-001 | 0.1 µmol / ～71 µg |
| Cyclic diguanosine monophosphorothioate, Sp- isomer ( Sp-c-diGMPS ) | C 125-005 | 5 x 0.1 µmol |
| Cyclic diguanosine monophosphorodithioate, Rp- isomers ( Rp,Rp-c-diGMPSS ) | C 129-001 | 0.1 µmol /～72 µg |
| Cyclic diguanosine monophosphorodithioate, Rp- isomers ( Rp,Rp-c-diGMPSS ) | C 129-005 | 5 x 0.1 µmol |
| Cyclic diguanosine monophosphorodithioate, Rp- / Sp- isomers ( Rp,Sp-c-diGMPSS ) | C 130-001 | 0.1 µmol /～72 µg |
| Cyclic diguanosine monophosphorodithioate, Rp- / Sp- isomers ( Rp,Sp-c-diGMPSS ) | C 130-005 | 5 x 0.1 µmol |
| 5'- Phosphoguanylyl- (3' −> 5')- guanosine ( pGpG ) | P 023-001 | 0.1 µmol / ～71 µg |
| 5'- Phosphoguanylyl- (3' −> 5')- guanosine ( pGpG ) | P 023-005 | 5 x 0.1 µmol |
| c-di-GMP(2'-5') | ||
| Cyclic diguanosine- (2' −> 5')- monophosphate / cyclic bis (2' −> 5') diguanylic acid ( c[G(2',5')pG(2',5')p] / 2',5'-2',5'-c-diGMP / c-diGMP(2'-5') ) | C 162-005 | 0.5 µmol / ～345 µg |
| Cyclic diguanosine- (2' −> 5')- monophosphate / cyclic bis (2' −> 5') diguanylic acid ( c[G(2',5')pG(2',5')p] / 2',5'-2',5'-c-diGMP / c-diGMP(2'-5') ) | C 162-025 | 5 x 0.5 µmol |
| c-di-ＩMP | ||
| Cyclic diadenosine monophosphate ( c-diAMP / c-di-AMP / cyclic bis (3' −> 5') diadenylic acid ) | C 105-01 | 1 µmol / ～0.7 mg |
| Cyclic diadenosine monophosphate ( c-diAMP / c-di-AMP / cyclic bis (3' −> 5') diadenylic acid ) | C 105-05 | 5 x 1 µmol |
For more information visit
http://www.biolog.de/products/eshop/category/c_diGMP_and_c_diAMP_Analogues/